Calliditas Therapeutics Ab ADR (CALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CALT | ZTS | TAK | UTHR | NBIX |
| Company | Calliditas Therapeutics Ab ADR | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 18.25 | 146.70 | 13.31 | 238.20 | 141.00 |
| High | 19.30 | 146.70 | 13.41 | 238.54 | 141.00 |
| Low | 17.50 | 146.70 | 13.30 | 233.77 | 141.00 |
| Last | 18.08 | 146.70 | 13.36 | 234.06 | 141.00 |
| Change | -0.62 | +1.16 | +0.12 | -3.87 | +7.34 |
| % Change | -3.30% | +0.80% | +0.91% | -1.63% | +5.49% |
| Volume | 2,900 | 1,052 | 1,561,400 | 552,400 | 7,378 |
| 20-Day Average Volume | 5,670 | 3,933,052 | 1,848,905 | 547,765 | 717,424 |
| Previous Close | 18.70 | 145.54 | 13.24 | 237.93 | 133.66 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 20.42 | 159.25 | 13.58 | 235.67 | 136.72 |
| 20-Day Raw Stochastic | 29.75% | 7.21% | 18.66% | 42.68% | 89.24% |
| 20-Day Relative Strength | 39.75% | 28.60% | 38.52% | 50.41% | 57.13% |
| Weighted Alpha | -22.71 | -23.08 | -19.58 | +3.26 | +42.45 |
| Today's Opinion | 40% Sell | 88% Sell | 100% Sell | 64% Buy | 96% Buy |
| Previous Opinion | 40% Sell | 88% Sell | 100% Sell | 80% Buy | 56% Buy |
| Last Month's Opinion | 56% Buy | 24% Sell | 56% Sell | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.58% since 04/15/24 | -4.13% since 04/16/24 | +1.37% since 04/15/24 | -0.43% since 04/15/24 | +6.02% since 04/16/24 |
| Low | 16.00 on 04/16/24 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 230.39 on 04/16/24 | 130.13 on 04/19/24 |
| High | 19.70 on 04/19/24 | 153.67 on 04/18/24 | 13.41 on 04/22/24 | 240.74 on 04/18/24 | 141.00 on 04/23/24 |
| 1-Month | |||||
| %Chg | -14.91% since 03/22/24 | -13.14% since 03/22/24 | -7.29% since 03/22/24 | -1.61% since 03/22/24 | -0.30% since 03/22/24 |
| Low | 16.00 on 04/16/24 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 221.53 on 04/01/24 | 130.13 on 04/19/24 |
| High | 23.00 on 04/09/24 | 171.14 on 03/28/24 | 14.45 on 03/26/24 | 250.89 on 03/26/24 | 142.31 on 03/26/24 |
| 3-Month | |||||
| %Chg | -22.36% since 01/22/24 | -22.01% since 01/23/24 | -9.67% since 01/22/24 | +8.24% since 01/22/24 | +0.42% since 01/23/24 |
| Low | 16.00 on 04/16/24 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 208.62 on 02/08/24 | 128.00 on 02/07/24 |
| High | 24.25 on 01/23/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 250.89 on 03/26/24 | 148.37 on 03/21/24 |
| 6-Month | |||||
| %Chg | +3.59% since 10/20/23 | -11.89% since 10/23/23 | -8.05% since 10/20/23 | +3.83% since 10/20/23 | +30.66% since 10/23/23 |
| Low | 15.25 on 11/13/23 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 208.62 on 02/08/24 | 103.63 on 11/10/23 |
| High | 29.30 on 12/26/23 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 258.31 on 12/14/23 | 148.37 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 538,678 | 66,564,024 | 42,281,968 | 11,014,628 | 13,300,106 |
| Shares Outstanding, K | 29,790 | 457,359 | 3,164,818 | 47,059 | 99,507 |
| Annual Sales | 113,810,000 | 8,544,000,000 | 29,803,340,000 | 2,327,500,000 | 1,887,100,000 |
| Annual Net Income | -43,960,000 | 2,344,000,000 | 2,345,930,000 | 984,800,000 | 249,700,000 |
| Last Quarter Sales | 42,450,000 | 2,213,000,000 | 7,556,070,000 | 614,700,000 | 515,200,000 |
| Last Quarter Net Income | -1,730,000 | 525,000,000 | 718,900,000 | 217,100,000 | 147,700,000 |
| 60-Month Beta | 1.51 | 0.85 | 0.53 | 0.52 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 02/21/24 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 4.36 on 02/21/24 | 1.44 on 02/07/24 |
| Latest Earnings Date | 05/21/24 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 27.54 | 6.79 | 11.99 | 54.55 |